Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Metadata
Title
In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis
Publication date
01-06-2005
Published in
Journal of Gastroenterology / Issue 6/2005
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-005-1596-x

Other articles of this Issue 6/2005

Journal of Gastroenterology 6/2005 Go to the issue

Editorial

Clinical significance of vascular assessment by contrast-enhanced harmonic ultrasonography of pancreatic carcinomas

Case report

D-Penicillamine improved laparoscopic and histological findings of the liver in a patient with Wilson’s disease: 3-year follow-up after diagnosis of Coombs-negative hemolytic anemia of Wilson’s disease

OriginalPaper

Effect of cigarette smoking on gastric emptying of solids in Japanese smokers: a crossover study using the 13C-octanoic acid breath test

OriginalPaper

Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment

Case report

Association of pseudomembranous colitis with Henoch-Schönlein purpura

Review

Enteroscopy

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits